Sign in
4/A

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-036201

President and CEO sold 18,756 shares at an average $17.50 ($328,260)

  • President and CEO acquired 18,756 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
McCarthy Sean A. President and CEO 2017-08-31 Option exercise +18,756 $0.95 $17,724 23,001 D
McCarthy Sean A. President and CEO 2017-08-31 Sale −6,562 $17.50 $114,835 16,439 D
McCarthy Sean A. President and CEO 2017-08-31 Sale −3,000 $17.51 $52,530 13,439 D
McCarthy Sean A. President and CEO 2017-08-31 Sale −9,194 $17.50 $160,895 4,245 D
Derivatives
McCarthy Sean A. President and CEO 2017-08-31 Option exercise · Stock Option (right to buy) −18,756 34,973 D
Open-market sales · 18,756 sh · avg $17.50 · $328,260
Loading xslF345X03/doc1.xml…